Trial
NCT05623488
CAR T Cells in Mesothelin-Expressing Breast Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pennsylvania
Collaborators
—
Condition
Breast Cancer
Intervention
huCART-meso cells
Why stopped
Feasibility Concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-12